Covered recipient · General Payments record
AHMAD GHORAB
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2019–2022
$824.70
- Reported across 15 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2022 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $428.96 | 7 |
| Education | $114.98 | 2 |
By paying entity
PY2022 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| SEAGEN INC. | $166.23 | 3 |
| GlaxoSmithKline, LLC. | $122.55 | 1 |
| E.R. Squibb & Sons, L.L.C. | $108.38 | 1 |
| Astellas Pharma US Inc | $79.07 | 2 |
| Gilead Sciences, Inc. | $50.00 | 1 |
| Amgen Inc. | $17.71 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2022 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $17.71 | 01/31/2022 | Food and Beverage | Undisputed | 01/23/2026 | 939723737 | CMS |
| Astellas Pharma US Inc | $59.99 | 09/07/2022 | Education | Undisputed | 01/23/2026 | 940265877 | CMS |
| Astellas Pharma US Inc | $19.08 | 11/14/2022 | Food and Beverage | Undisputed | 01/23/2026 | 940320031 | CMS |
| E.R. Squibb & Sons, L.L.C. | $108.38 | 07/07/2022 | Food and Beverage | Undisputed | 01/23/2026 | 932813177 | CMS |
| Gilead Sciences, Inc. | $50.00 | 09/28/2022 | Food and Beverage | Undisputed | 01/23/2026 | 929647151 | CMS |
| GlaxoSmithKline, LLC. | $122.55 | 10/20/2022 | Food and Beverage | Undisputed | 01/23/2026 | 944932419 | CMS |
| Seagen Inc. | $86.85 | 06/30/2022 | Food and Beverage | Undisputed | 01/23/2026 | 904101241 | CMS |
| Seagen Inc. | $54.99 | 07/08/2022 | Education | Undisputed | 01/23/2026 | 904101251 | CMS |
| Seagen Inc. | $24.39 | 10/26/2022 | Food and Beverage | Undisputed | 01/23/2026 | 904101293 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022
- Generated from
- OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.